Abstract:Background & Aims: Metastasis is found in most advanced hepatocellular carcinoma (HCC) patients, and it drives tumor recurrence and systemic failure. There is no effective treatment owing to its complex biological features. Many of the molecular drivers of metastasis are crucial players in normal physiology but behave unconventionally during cancer progression. Targeting these molecular drivers for therapy and differentiating them from a physiological background require a detailed examination of the novel mechanisms involved in their activation during metastasis. Methods: Publicly available transcriptomic data such as that of TCGA-LIHC and Gene Expression Omnibus were utilized to identify novel targets upregulated in advanced and metastatic HCC. Validation of candidates was assisted by immunohistochemistry performed on tissue microarrays derived from more than 100 HCC patients. Expression of protein tyrosine kinase 7 (PTK7) was studied under the treatment of transforming growth factor-β1 and knockdown of SRY-Box Transcription Factor 9 (SOX9) to delineate upstream regulation, while CRISPR-mediated knockout and lentiviral overexpression of PTK7 in HCC cells were performed to study their functional and signaling consequences. Manipulated HCC cells were injected into mice models either by orthotopic or tail-vein injection to observe for any in vivo pro-metastatic effects. Results: PTK7 was discovered to be the kinase most significantly upregulated in advanced and metastatic HCC, at both transcriptomic and proteomic level. Bioinformatic analyses and functional assays performed in HCC cell lines revealed transforming growth factor-β signaling and SOX9 to be important activators of PTK7 expression. Functionally, enrichment of PTK7 expression could positively regulate metastatic potential of HCC cells in vitro and in lung metastasis models performed in immunodeficient mice. The up-regulation of PTK7 recruited the epithelial–mesenchymal transition components, zinc finger protein SNAI2 (SLUG) and zinc finger E-box-binding homeobox 1 (ZEB1). Conclusions: Our study proposes PTK7 as a novel molecular driver in metastatic HCC, particularly in a transforming growth factor-β–activated microenvironment. The preferential expression of PTK7 resulted in a previously unobserved regulatory effect on the recruitment of epithelial–mesenchymal transition components, which established PTK7 as a potential determinant of specific epithelial–mesenchymal transition status. Therefore, our data support the continual development of PTK7-targeted agents as antimetastatic therapies.

HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2

COMMD7 is Correlated with a Novel NF-κB Positive Feedback Loop in Hepatocellular Carcinoma.

A Negative Feedback Loop Between KLF9 and the EMT Program Dictates Metastasis of Hepatocellular Carcinoma.

Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling.

Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β SignalingSummary

CKLF1 Enhances Inflammation-mediated Carcinogenesis and Prevents Doxorubicin-induced Apoptosis via IL-6/STAT3 Signaling in HCC.

Up-regulation of Krüppel-like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma.

Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression Through Activation of Hepatocyte Nuclear Factor-6.

FGF19/FGFR4-mediated Elevation of ETV4 Facilitates Hepatocellular Carcinoma Metastasis by Upregulating PD-L1 and CCL2

Dysregulated Krüppel-like Factor 4 and Vitamin D Receptor Signaling Contribute to Progression of Hepatocellular Carcinoma.

Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice

KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression

Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3

Hepatocyte Nuclear Factor 4 Alpha-Nuclear Factor-Kappa B Feedback Circuit Modulates Liver Cancer Progression

MiR-7 Inhibits Progression of Hepatocarcinoma by Targeting KLF-4 and Promises a Novel Diagnostic Biomarker

Suppression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells by Krüppel-like Factor 4.

CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression

Comprehensive Analysis of KLF2 As a Prognostic Biomarker Associated with Fibrosis and Immune Infiltration in Advanced Hepatocellular Carcinoma.

Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway

SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis.

Down-regulation of Krüppel-like Factor-4 by Microrna-135A-5p Promotes Proliferation and Metastasis in Hepatocellular Carcinoma by Transforming Growth Factor-Β1